-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991464&selectedPageVersions=1&selectedPageVersions=2
September 23, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991470
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991557
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991464
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991462&pageId=114991464
September 23, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence//display/PUB/Learning+Health+Systems
October 05, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991557
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991470
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991464
September 24, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=1&pageId=114990972&revisedVersion=5
September 23, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114990972
October 05, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/display/PUB/Learning+Health+Systems
October 05, 2021 - outcomes: morbidity, mortality, opioid CDS aligned with opioid-related death and adverse drug events, ED/hospitalization
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991683
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team recognized the importance of hypercoagulability in COVID-19 and wanted to provide evidence-based …
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991775
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team recognized the importance of hypercoagulability in COVID-19 and wanted to provide evidence-based …
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991777
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team recognized the importance of hypercoagulability in COVID-19 and wanted to provide evidence-based …
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991688
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team recognized the importance of hypercoagulability in COVID-19 and wanted to provide evidence-based …
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991656
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team (MHealth Fairview) recognized the importance of hypercoagulability in COVID-19 and wanted to prov…
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991655
August 31, 2021 - Working DRAFT for Stakeholder Input and Refinement University of Minnesota Efforts to Optimize Anticoagulant use in COVID-19 Patients Soon after the COVID-19 Pandemic began in early 2020, the University of Minnesota team (MHealth Fairview) recognized the importance of hypercoagulability in COVID-19 and wanted to prov…
-
cmext.ahrq.gov/confluence/download/temp/download6Ocmv003901.zip?contentType=application/zip
November 11, 2019 - Care Plans.pptx
image2021-8-23_11-11-19.png
image2021-8-26_17-1-9.png
image2021-8-26_17-0-24.png
image2021-8-20_17-41-58.png
image2021-8-23_11-0-47.png
image2021-8-26_17-0-13.png
image2021-8-27_8-50-9.png
image2021-8-23_11-6-16.png
/docProps/thumbnail.jpeg
…
-
cmext.ahrq.gov/confluence/download/export/downloadSCo68131941.zip?contentType=application/zip
November 11, 2019 - Care Plans.pptx
image2021-8-23_11-11-19.png
image2021-8-26_17-1-9.png
image2021-8-26_17-0-24.png
image2021-8-20_17-41-58.png
image2021-8-23_11-0-47.png
image2021-8-26_17-0-13.png
image2021-8-27_8-50-9.png
image2021-8-23_11-6-16.png
/docProps/thumbnail.jpeg
…